Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
313.89
+8.18 (2.68%)
May 11, 2026, 9:38 AM EDT - Market open
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $9.25 billion as of May 11, 2026. Its market cap has increased by 89.94% in one year.
Market Cap
9.25B
Enterprise Value
8.00B
1-Year Change
89.94%
Ranking
Category
Stock Price
$313.89
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $9.25B, an increase of 9,914.50%. That is a compound annual growth rate of 70.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 9.01B | 26.06% |
| Dec 31, 2025 | 7.15B | 58.67% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 11.19B |
| BioMarin Pharmaceutical | 10.45B |
| Arrowhead Pharmaceuticals | 10.18B |
| ABIVAX Société Anonyme | 9.83B |
| Cytokinetics | 9.57B |
| Praxis Precision Medicines | 9.19B |
| ImmunityBio | 8.91B |
| Nuvalent | 8.31B |